EconPapers    
Economics at your fingertips  
 

Latin America’s embrace of an unproven COVID treatment is hindering drug trials

Emiliano Rodríguez Mega

Nature, 2020, vol. 586, issue 7830, 481-482

Abstract: Unchecked ivermectin use in the region is making it difficult to test the anti-parasite drug’s effectiveness against the coronavirus.

Keywords: SARS-CoV-2; Public health; Medical research; Health care; Government; Diseases (search for similar items in EconPapers)
Date: 2020
References: Add references at CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://www.nature.com/articles/d41586-020-02958-2 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:586:y:2020:i:7830:d:10.1038_d41586-020-02958-2

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-020-02958-2

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:nature:v:586:y:2020:i:7830:d:10.1038_d41586-020-02958-2